Azithromycin Powder, For Suspension
NDC Package 50090-8144-0

11-digit billing NDC: 50090814400

Package Information

Azithromycin powders is azithromycin for oral suspension is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. This formulation utilizes a powder, for suspension delivery system. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-8144 and is authorized under FDA application ANDA217036.

Identification & Billing

NDC Package Code
50090-8144-0
Package Description
1 BOTTLE in 1 CARTON / 30 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
50090814400

Clinical Specifications

Proprietary Name
Azithromycin
Non-Proprietary Name
Azithromycin
Substance Name
Azithromycin Dihydrate
Dosage Form
Powder, For Suspension - An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle).
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Azithromycin for oral suspension is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications. [see Dosage and Administration (2)]

Regulatory & Marketing

Labeler Name
A-s Medication Solutions
Product Type
Human Prescription Drug
FDA Application #
ANDA217036
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-16-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50090-8144-0 identifies a specific commercial package of 1 bottle in 1 carton / 30 ml in 1 bottle of Azithromycin, a human prescription drug labeled by A-s Medication Solutions. This powder, for suspension is formulated for oral use and contains azithromycin dihydrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by A-s Medication Solutions on January 16, 2026. The current certification is valid through December 31, 2027.

How is this A-s Medication Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090814400. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50090-8144-0
11-Digit CMS (5-4-2)
50090-8144-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.